scispace - formally typeset
Open AccessJournal ArticleDOI

Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.

A J MacGilchrist, +6 more
- 01 Feb 1986 - 
- Vol. 27, Iss: 2, pp 190-195
TLDR
Significant delay in the elimination of midazolam and decreased psychomotor function in patients with severe alcoholic liver disease is shown and Caution is needed in using this drug for premedication in such patients before endoscopy.
Abstract
Midazolam kinetics and psychomotor function were studied after an intravenous dose of 0.075 mg/kg body weight in seven patients with alcoholic cirrhosis and eight control patients. Four of the seven cirrhotics died of complications of their liver disease within six months of the study. The metabolism of midazolam was significantly impaired in the cirrhotic patients (p less than 0.025). These patients also had evidence of greater sedation than the control group for up to six hours after the dose was administered (p less than 0.05). The clearance of midazolam did not correlate significantly with the serum albumin, or bilirubin, or with the kinetics of antipyrine, or indocyanine green. This study shows significant delay in the elimination of midazolam and decreased psychomotor function in patients with severe alcoholic liver disease. Caution is needed in using this drug for premedication in such patients before endoscopy.

read more

Citations
More filters
Journal ArticleDOI

In vitro and in vivo drug interactions involving human cyp3a

TL;DR: Cytochrome P4503A (CYP3A) is importantly involved in the metabolism of many chemically diverse drugs administered to humans and makes it a major contributor to presystemic elimination following oral drug administration.
Journal ArticleDOI

Pharmacokinetics and dosage adjustment in patients with renal dysfunction

TL;DR: It is shown that renal dysfunction affects more that just the renal handling of drugs and/or active drug metabolites, and a re-evaluation of markers of renal function may be required, even when the dosage adjustment recommended for patients with renal dysfunction are carefully followed.
Journal ArticleDOI

Update on bispectral index monitoring.

TL;DR: BIS technology is moving out of the operating room and into diverse environments where conscious and deep sedation are provided, and anesthesiologists need to be actively involved in promoting patient safety and helping transition this technology into broader use.
References
More filters
Journal ArticleDOI

A physiological approach to hepatic drug clearance

TL;DR: The proposed classification of drug metabolism based on the hepatic extraction ratio allows prediction and interpretation of the effects of individual variations in drug‐metabolizing activity, route of administration, pharmacokinetic interactions, and disease states on hepatic drug elimination.
Journal ArticleDOI

The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

TL;DR: The constancy of diazepam clearance indicates that drug plasma concentrations will not accumulate any more in the old than the young, and chronic dosage modifications based on pharmacokinetic considerations are unnecessary.
Journal ArticleDOI

Clearance concepts in pharmacokinetics

TL;DR: The kinetics of a drug eliminated by first-order processes in a perfusion-limited isolated perfused organ system are examined and the virtue of using clearance, instead of half-life, as a correlative parameter between these systems is stressed.
Journal ArticleDOI

Psychomotor Function and Psychoactive Drugs

TL;DR: A cursory review of the literature reveals that the techniques used to assess psychomotor functions are diverse, often complex, frequently insensitive to drug induced changes and sometimes inconvenient to enact or replicate.
Related Papers (5)